Home > Financial Ratios > KREBS BIOCHEMICALS & INDUSTRIES

KREBS BIOCHEMICALS & INDUSTRIES
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for KREBS BIOCHEMICALS & INDUSTRIES
Please provide your vote to see the results

KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) -17.30-30.27-56.94-32.73-55.53

What is the latest Core EBITDA Margin ratio of KREBS BIOCHEMICALS & INDUSTRIES ?

The latest Core EBITDA Margin ratio of KREBS BIOCHEMICALS & INDUSTRIES is -17.30 based on Mar2024 Standalone results.
Year Core EBITDA Margin
Mar2024-17.30
Mar2023-30.27
Mar2022-56.94
Mar2021-32.73
Mar2020-55.53

How is Core EBITDA Margin of KREBS BIOCHEMICALS & INDUSTRIES Trending?

Years Core EBITDA Margin % Change
Mar2024 -17.3
Negative
Mar2023 -30.27
Negative
Mar2022 -56.94
Negative
Mar2021 -32.73
Negative
Mar2020 -55.53 -

Other Financial Ratios of KREBS BIOCHEMICALS & INDUSTRIES


Compare Core EBITDA Margin ratio of peers of KREBS BIOCHEMICALS & INDUSTRIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KREBS BIOCHEMICALS & INDUSTRIES ₹175.0 Cr 2.9% 8.5% -5.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹391,368.0 Cr 2.1% 0.3% -9.6% Stock Analytics
DIVIS LABORATORIES ₹160,631.0 Cr -0% 1.1% 13.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹123,641.0 Cr 3.4% 0.2% 8.1% Stock Analytics
CIPLA ₹123,419.0 Cr -1.1% -3.2% -4.6% Stock Analytics
DR REDDYS LABORATORIES ₹109,176.0 Cr -0.7% 2% 0.7% Stock Analytics


KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KREBS BIOCHEMICALS & INDUSTRIES

2.9%

8.5%

-5.8%

SENSEX

-0.3%

0.1%

-1%


You may also like the below Video Courses